3 August 2010
Fornix Half-Yearly Report 2010
Abridged consolidated interim financial statements for the first half year 2010

5 July 2010
Sale of  Fornix Allergy division to ALK-Abello completed

29 June 2010
Fornix shareholders approve sale of Allergy division

1 June 2010
Announcement of the EGM
(only available in the Dutch language)
Shareholder Circular
Agenda of the EGM

1 June 2010
Sale of Dutch Allergy Division to ALK-Abello

7 May 2010
Fornix publishes trading update for first four months of 2010

26 April 2010
Fornix announces the proposed divestment of its Dutch
Allergy division to ALK-Abello for a purchase price of
€ 19,6 million in cash

23 April 2010
AGM approves payment of special dividend

23 April 2010
Fornix is discussing sale of its allergy division

Welcome to the Fornix BioSciences N.V. corporate information page

With reference to the transaction of the Allergy division the website of Fornix shall be renewed in the coming months.

Fornix BioSciences is a listed company (Euronext Amsterdam: AFORBI) which engages mainly in the distribution of medical aids, the distribution of medical and nursing disposables.

On 29 June 2010 for 10:30 hours Fornix BioSciences N.V. has hold her Extraordinary Annual General Meeting of Shareholders. As from this date the Extraordinary General Meeting of Shareholders is live by means of audio web cast (available in the Dutch language). Click here to activate the audio web cast.